Source link : https://www.newshealth.biz/health-news/fda-expands-benralizumab-use-for-asthma-to-kids-over-age-6/
Benralizumab is now approved by the US Food and Drug Administration for the treatment of asthma in children older than 6 years. Marketed as Fasenra, the medication first was approved in 2017 for patients aged 12 years or older. The drug is approved as a maintenance add-on for patients with severe eosinophilic asthma. AstraZeneca, which […]
Author : News Health
Publish date : 2024-04-11 18:21:40
Copyright for syndicated content belongs to the linked Source.